Objective: To examine growth, neurodevelopment and morbidity in infants with gastroschisis.
Introduction
Infants with gastroschisis are born with the intestines herniated through a small defect in the abdominal wall. The birth prevalence of gastroschisis is increasing, and is now estimated to be 4.5 per 10 000 liveborn infants. 1 Survival is greater than 90%. 2, 3 The most common neonatal morbidities associated with gastroschisis include gastroesophageal reflux disease (GERD), feeding intolerance due to prolonged intestinal dysmotility and sepsis. 4 Infants with gastroschisis frequently have risk factors for impaired growth and delayed neurodevelopment, including premature birth, small for gestational age (SGA) or nutritional compromise early in life. 5 Approximately 67% of infants with gastroschisis are born prematurely, 6 20% are SGA, 7 and 15 to 20% experience prolonged intestinal dysfunction requiring parenteral nutrition for longer than 4 weeks. 6 The impact of gastroschisis on growth and neurodevelopment, based on previous studies, is uncertain because of limitations in study design, including small cohort sizes, the inclusion of patients with unrelated abdominal wall defects, evaluations by report only and the inclusion of patients born greater than 20 years ago. [8] [9] [10] [11] As a result, some studies report normal growth, and others report a high percentage of growth failure. [11] [12] [13] Neurodevelopmental findings also vary, with both impaired development 8 and normal development 12 reported. Advances over the past 15 years in neonatal care, including improved respiratory management and parenteral nutrition, may have improved long-term growth and neurodevelopment. The objective of this study was to estimate the impact of gastroschisis on longitudinal growth, neurodevelopment and comorbidities among infants managed with contemporary respiratory and nutritional interventions.
Methods
This case series included all infants born between March 2003 and June 2005, and treated for gastroschisis at the North Carolina Children's Hospital (NCCH). All infants with gastroschisis were included, regardless of comorbid conditions. Infants were recruited for participation after initial discharge from the hospital. Written informed consent was obtained from the parents or legal guardians. This study was approved by the University of North Carolina Institutional Review Board.
We collected data from a chart review of the neonatal record. Data collected included maternal and infant demographics; mode of delivery; gestational age; growth parameters at birth; enteral feeding characteristics, including postnatal day when enteral feedings were initiated and goal enteral feedings were achieved; complications of surgery; method of abdominal wall closure and length of initial hospitalization. The definition of goal enteral feedings was determined by the attending physician and generally corresponded to 100 kcal/kg per day of enteral feeds. The time to achieve goal enteral feeds corresponded to the discontinuation of parenteral nutrition.
Using a standardized growth curve, 14 an infant whose birth weight was less than the 10th percentile for gestational age was considered to be SGA. We defined prematurity as gestational age less than 37 weeks, as determined by obstetrical dating, and confirmed with initial postnatal exam. The gastroschisis lesion was considered to be complex if atresia or necrosis was present, or if bowel was resected. Short bowel syndrome was defined as dependence on parenteral nutrition at the time of initial hospital discharge. We defined GERD as treatment with gastric motility or acid-reducing medications.
Between 16 and 24 months of age, adjusted for prematurity, infants were evaluated in the Special Infant Care Clinic at the NCCH. Weight, length and head circumference were measured. Centers for Disease Control growth standards were used to obtain percentiles and z-scores for each measurement, according to age and gender, and adjusted for prematurity. 15 The z-score represents how many units of the standard deviation (s.d.) an individual is above or below the standardized mean. Z-scores were calculated to nullify the effects of age and gender on growth measurements. A z-score of À1.28 corresponds to the 10th percentile.
We assessed neurodevelopment using the Bayley Scales of Infant Development, second edn (BSID-II). 16 The child's primary caregiver completed a medical history questionnaire that included data regarding postneonatal hospitalizations, bowel habits and general well-being. We used the Rome Criteria for identifying functional bowel problems in children to identify chronic constipation and diarrhea. 17, 18 The Functional Status II questionnaire was used to estimate the effect of gastroschisis on daily life. 19 The relationship between neonatal variables, including SGA, prematurity and length of initial hospitalization, and the primary outcome variables of growth and neurodevelopment were evaluated. Student's t-test and linear regression analysis were used to assess these associations. All analyses were performed using Intercooled Stata 9.2 for Windows (Stata, College Station, TX, USA).
Results
A total of 27 infants were eligible for the study, with 17 infants completing follow-up. One infant had incomplete data acquisition, and six infants were lost to follow-up. One infant died in the neonatal period secondary to amniotic fluid aspiration and pulmonary hypertension, and two infants died after initial hospital discharge secondary to complications of short bowel syndrome. Demographic and neonatal characteristics of the study cohort are presented in Table 1 . Gestational age, birth weight, gender, race, birth at a tertiary care center, SGA, birth weight z-score, method of abdominal wall closure and length of initial hospitalization were similar between those who completed the study and those who did not.
Of 17 infants who completed follow-up, 11 were born prematurely, and 6 were SGA. Five infants had primary surgical closure of the defect, and the remainder had delayed closure after placement of a silo and sequential reduction. Two infants had complex lesions, with one infant having necrosis, and a second infant having necrosis with atresia. One infant developed short bowel syndrome. Enteral feeds were begun at a mean age of 17 days with a s.d. of 12 days. Excluding one infant dependent on parenteral nutrition at discharge, the mean age when goal enteral feeds were attained was 31 days. Duration of initial hospitalization ranged from 21 to 50 days. Comorbid conditions were evaluated for each infant. No infant had findings consistent with a chromosomal anomaly or genetic condition. However, karyotypes were not routinely obtained. The mean age at follow-up was 20 months. The mean z-scores for weight, length and head circumference at follow-up were À0.26, À0.14 and 0.36, respectively (Table 2 ). Five infants (29%) had z-scores less than À1.28 (10th percentile) for weight, and six infants (35%) were less than À1.28 (10th percentile) for length. All five infants who had z-scores less than À1.28 (10th percentile) for weight were also less than À1.28 (10th percentile) for length. No infant had a z-score for head circumference less than À1.28 (10th percentile). Mean weight z-score increased from À0.64 at birth to À0.26 at follow-up. Paired sample t-test did not demonstrate a difference (P ¼ 0.15).
The mean Mental Developmental Index (MDI) and mean Psychomotor Development Index (PDI) on the BSID-II were both 101 (Table 2) . Three infants had an MDI of less than 85 (one s.d. below the mean), whereas one infant had an MDI of less than 70 (two s.d.s below the mean). One infant had a PDI of less than 85, and this child also had an MDI of less than 85. No infant had a PDI of less than 70. The neurologic examination was normal for all infants.
Prematurity and intrauterine growth restriction were associated with poor growth and neurodevelopment ( Table 2 ). The mean weight z-score at follow-up for SGA infants was À1.34, whereas infants who were not SGA had a mean weight z-score of 0.5 (P<0.01). Infants who were SGA also had lower MDI and PDI scores, although there was no statistical association. Preterm infants had lower PDI scores than term infants. There was an association between the length of initial hospitalization and low-length z-score (P ¼ 0.05) and a lower MDI (P ¼ 0.01).
Morbidities after initial hospital discharge are shown in Table 3 . A total of 9 of the 17 infants were rehospitalized. Four infants were rehospitalized due to complications of gastroschisis, including central line infection, intestinal obstruction and bowel reanastomoses after ostomy. Other reasons for hospitalization included seizures (one), respiratory illness (three) and orchiopexy (one). Of 17 infants, 6 (35%) had a history of chronic diarrhea, and 10 (59%) had a history of chronic constipation. Three infants scored less than 90% on the Functional Status II.
Discussion
The rising birth prevalence of gastroschisis and the high survival rate of infants with this malformation increase the importance of understanding associated long-term outcomes. Our findings represent the largest contemporary long-term study of infants with gastroschisis, and describe the growth and development of these infants. Consistent with previous reports, 65% of our cohort were preterm, and 35% were born SGA. Our findings suggest compromised longitudinal growth in infants with gastroschisis, with nearly one-third less than the 10th percentile for weight at 16 to 24 months adjusted age. Infants born SGA and infants born prematurely are particularly at risk. In contrast, we demonstrated normal neurodevelopment in most infants of our cohort, although infants who were SGA or premature scored lower compared to appropriately grown and full-term infants.
Impaired long-term growth of infants with gastroschisis has been described previously. [8] [9] [10] [11] 13 In studies published more than 20 years ago, 30 to 40% of survivors were less than the 10th percentile for weight at follow-up. 8, 13, 20 Berseth et al. 8 described a case series of infants with either gastroschisis or omphalocele, who were born between 1964 and 1977, and observed minimal catch-up growth for both weight and length. However, more recently published studies suggest that growth of infants with gastroschisis may be improving. Davies and Stringer 9 conducted 11 studied infants with gastroschisis born between 1985 and 1996. Among this cohort, both length and weight were less than the third percentile at initial follow-up in 36%, which occurred at 6 months to 10 years of age. However, 3 years later all were greater than the 10th percentile. The authors did not report on the characteristics of infants who showed catch-up growth after the initial evaluation. In our study, the large number of infants with suboptimal growth may reflect improved survival of potentially more vulnerable infants, or may be a result of the earlier age at which follow-up was completed.
Our data suggest that the impaired growth seen in infants with gastroschisis is primarily related to SGA. Impaired longitudinal growth among SGA infants in our study is consistent with published reports of poor catch-up growth among other populations of SGA infants. 21, 22 Most SGA infants will experience some catch-up weight and length growth in the first 6 to 12 months after birth, although they remain smaller and lighter on average than infants appropriately grown at the time of birth. 21 However, an unusual feature of our cohort, compared to a general population of infants, is the high prevalence of fetal growth restriction. This observation suggests that impaired postnatal growth may be caused by intrinsic factors associated with gastroschisis that limit growth both during fetal development and infancy. Alternatively, poor postnatal growth may be secondary to suboptimal postnatal nutrition, and therefore, may be modifiable with improved nutrition. In addition, marked catch-up growth in infants with gastroschisis may occur after 24 months, the end point of our evaluation.
Fetal growth restriction and SGA at birth have been associated with developmental delay, particularly among infants born prematurely. 23, 24 In SGA infants, developmental outcome is influenced by underlying disease processes, such as congenital infection, placental insufficiency or chromosomal anomalies. Because neurodevelopment was not compromised in this study cohort, gastroschisis does not appear to add to this risk of neurodevelopmental impairment.
Most previous studies of neurodevelopment among infants with gastroschisis suggest a prevalence of impairment greater than the general population, and greater than observed in our cohort. 8, 11, 12, 23 Lunzer et al. 11 conducted interviews of parents of 10 gastroschisis survivors at 3 to 12 years of age. Two reported a learning disability, and one reported mental retardation. In a combined study of gastroschisis and omphalocele, Berseth et al. 8 reported standardized intelligence quotient (IQ) test scores of less than 90 for 35% of the cohort. By contrast, another study of combined abdominal wall defects reported normal IQ, but nearly 20% had evidence of moderate or severe learning disability. 25 Developmental delay has been reported in 3 of 26 infants with gastroschisis as evaluated by parental questionnaire. 12 Comparing the results of previous studies to a contemporary cohort of infants with gastroschisis is problematic for several reasons. First, the outcome of cohorts that include all abdominal wall defects may be influenced by the comorbid conditions associated with different lesions. For example, omphalocele is associated with chromosomal anomalies, which are known to affect neurodevelopment. Second, outcomes of contemporary cohorts may be improved because of advances in respiratory management. Specifically, decreased length of time on mechanical ventilation, less injurious modes of ventilation and the use of surfactant have all resulted in decreased pulmonary morbidity in these patients, all of which could affect initial weight gain, and ultimately affect neurodevelopment, independent of the presence of gastroschisis. Third, there have been advances in our ability to meet the nutritional needs of infants with poor intestinal function through the provision of earlier, more complete and less injurious parenteral nutrition. Finally, recent changes in surgical management, with greater use of delayed abdominal closure, could impact long-term outcome through differences in time to initiate feeds, length of time on mechanical ventilation and risk of sepsis. 26 The uncompromized neurodevelopment observed in our cohort may be the result of a combination of contemporary treatment strategies.
In the neonatal period, many infants with gastroschisis have early bowel dysfunction. 3 In our cohort, early bowel dysfunction was followed by continued functional bowel disorders during infancy, with 59% of the cohort reporting constipation and 35% reporting chronic diarrhea. These findings are consistent with previous studies in which the incidence of patients reporting constipation and diarrhea ranged from 16 to 50%. 10, 27 These bowel disorders may have affected nutrient absorption and altered feeding practices, and therefore be related to the suboptimal growth seen in our cohort.
The rate of surgical complications, both directly and indirectly related to gastroschisis, appears to be decreasing. In our study, only two infants required reoperation, one for ostomy takedown and one for cryptorchidism. Davies and Stringer 9 reported that 70% of infants required an operative procedure after discharge, with 35% of procedures directly related to the gastroschisis. Tunell et al. 27 reported that 32% of infants with abdominal wall defects required reoperation due to complications of the defect. The improved rate of surgical complications seen in our study may be due to improvements in surgical management of these infants.
Although surgical complications were unusual, rehospitalization continues to be common among infants with gastroschisis, occurring in over 50% of our cohort. Four of the nine rehospitalizations were directly related to the gastroschisis, with problems of bowel obstruction, diarrhea, central venous line infection or ostomy takedown. Acute respiratory disease accounted for the remainder of admissions, and although not directly related to gastroschisis, may have been influenced by the late-preterm birth of these infants.
Despite impaired growth and the functional bowel disorders experienced by the infants in this cohort, results of the Functional Status II questionnaire indicate only a minimal effect of gastroschisis on quality of life. This is consistent with an informal questionnaire-based study that showed 80% of 66 patients with gastroschisis to be in good or excellent health, and with a 'good' quality of life. 27 Self-reported problems negatively influencing quality of life included short stature, inadequacy in sports or social events and gastrointestinal problems. 27 There are several limitations to this study. Although follow-up data were collected in a prospective fashion, data on the initial hospital course were collected retrospectively, and therefore relied on information in the medical record. The small size of the cohort limits our ability to draw definitive conclusions. Of 24 surviving patients, 7 were unable to be included in the analysis. We cannot be certain that infants who were lost to follow-up had outcomes that were comparable to the cohort reported in this study. Specific information on dietary intake, early feeding strategies, longitudinal growth and developmental follow-up at a more advanced age would be useful in more specifically explaining the findings of this study.
In conclusion, our study demonstrates that infants with gastroschisis have compromised longitudinal growth, but normal neurodevelopment over the first 16 to 24 months after birth. Several factors, including SGA, prematurity and prolonged hospitalization, appear to be markers for poor growth and compromised neurodevelopment. Possible strategies to optimize appropriate weight and length attainment include studying and implementing best nutrition practices, along with close monitoring of growth. Finally, counseling parents of infants with gastroschisis should include discussions about the possibility for prolonged bowel dysfunction and rehospitalization.
